FIELD: medicine.
SUBSTANCE: invention refers to medicine, in particular to ophthalmology and can be used for early diagnostics of premature retinopathy. Newborns born with body weight less than 1500 g and gestation term less than 32 weeks are tested for haemoglobin and erythrocyte content in 1 month after birth. If haemoglobin content is 110 g/l and less, and erythrocyte content is less than 4.0×1012 g/l, high disease factor is predicted.
EFFECT: higher accuracy of prediction and early detection of children with high premature retinopathy factor.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING DEVELOPMENT OF THRESHOLD STAGE OF RETHINOPATHY OF PREMATURITY IN CHILDREN WITH EXTREMELY LOW WEIGHT | 2016 |
|
RU2641161C1 |
METHOD FOR PREDICTION OF EARLY ANAEMIA OF PREMATURE NEWBORNS | 2019 |
|
RU2719657C1 |
METHOD FOR PREDICTION OF EARLY ANEMIA OF PREMATURE NEWBORNS | 2019 |
|
RU2699657C1 |
METHOD FOR PREDICTION OF DEVELOPING EARLY PREMATURE ANAEMIA OF PREMATURE INFANTS REQUIRING HAEMOTRANSFUSION | 2019 |
|
RU2719656C1 |
PREDICTION METHOD OF PREMATURE RETINOPATHY LASER COAGULATION USE | 2016 |
|
RU2621307C1 |
METHOD FOR PREDICTING THE FORMATION OF THE THRESHOLD STAGE OF RETINOPATHY OF PREMATURE INFANTS WITH EXTREMELY LOW BIRTH WEIGHT IN THE EARLY NEONATAL PERIOD | 2018 |
|
RU2677464C1 |
METHOD FOR PREDICTION OF DEVELOPING LATE ANAEMIA OF PREMATURE NEWBORNS | 2020 |
|
RU2741514C1 |
PREDICTION METHOD OF PREMATURE RETINOPATHY ACTIVE PHASE DEVELOPMENT | 2016 |
|
RU2618395C1 |
METHOD FOR PREDICTING DEVELOPMENT OF RETINOPATHY IN PREMATURE BABIES | 2001 |
|
RU2216740C2 |
METHOD FOR PREDICTION OF FUNCTIONING OF ARTERIAL DUCT IN PREMATURE NEWBORNS | 2019 |
|
RU2707061C1 |
Authors
Dates
2008-11-10—Published
2007-07-18—Filed